BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

MediLink Therapeutics Partners with Roche for Oncology Antibody Drug Conjugate

Under the terms of the agreement, MediLink will grant Roche exclusive global rights for the development, manufacturing, and commercialization of MediLink's...

January 03, 2024 | News

NeuroBo Pharma Seeks FDA Approval for Obesity Treatment Trial

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, anno...

January 02, 2024 | News

Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...

January 01, 2024 | News

TiumBio Raises KRW 38.5B for Upcoming Clinical Data

The proceeds will fund its robust clinical programs and bolster TiumBio's financial position. Data read-outs from a Phase 2 trial of merigolix...

January 01, 2024 | News

Recbio's REC610 Shingles Vaccine Shows Positive Interim Trial Results in the Philippines

Previously, the Company conducted a GSK Shingrix® active-controlled FIH clinical trial of REC610 in the Philippines. The Interim Analysis (IA) res...

December 29, 2023 | News

Biocytogen and CtM Bio Advance in Developing Multi-Specific T Cell Engager against WT1/HLA-A02

In just one year since the start of the collaboration, the companies have identified a WT1/HLA-A02-specific T cell engager (WT1xCD3x4-1BB tri-specific anti...

December 28, 2023 | News

Bristol Myers Squibb Acquires RayzeBio, Enhancing Radiopharmaceutical Portfolio

Lead Program, RYZ101, in Phase 3 Development for Treatment of Gastroenteropancreatic Neuroendocrine Tumors and Early-stage Development for Treatment ...

December 27, 2023 | News

Oncoshot Collaborates with Zhejiang Ablaze for Data-Driven Drug Development in China

This collaboration brings together complementary strengths - Oncoshot's capabilities in data analysis and insights generation with Ablaze's recent expansio...

December 26, 2023 | News

Thermo Fisher's PPD Chosen by BARDA for ARDS Phase II Trial Support

ARDS is a life-threatening lung condition with multiple causes, including severe pneumonia and sepsis due to bacterial and viral infections such as influen...

December 22, 2023 | News

CellOrigin Treats First CAR-M Patient in China, Unveils Second-Gen CAR-M for Solid Tumors

"A single center, single-arm, dose-escalation, exploratory clinical trial to examine the safety, tolerability, pharmacokinetics and prelimina...

December 21, 2023 | News

Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome

Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were con...

December 19, 2023 | News

NUS Researchers in Singapore Innovate Flexible Method for Immune Cell Study

Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by path...

December 19, 2023 | News

Illumina and HaploX Collaborate on Benchtop Sequencing System

This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localized manufacturing of ...

December 13, 2023 | News

IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific

In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...

December 13, 2023 | News

Stay Connected